InvestorsHub Logo
Followers 15
Posts 697
Boards Moderated 0
Alias Born 10/03/2017

Re: None

Wednesday, 03/16/2022 9:17:48 AM

Wednesday, March 16, 2022 9:17:48 AM

Post# of 426330
SEC finally doing something to help Amarin:

Residual cardiovascular risk: what is the role of icosapent ethyl?
CardioVascular Virtual Topics 2022 (#CVVT2022)
10 May 2022 livestream on YouTube

https://secardiologia.es/multimedia/directos-online/ciclos/cvvt-2022/13125-sesion-2

PARTICIPANTS
Prof. José Luis Zamorano
Hospital Universitario Ramón y Cajal, Madrid (Spain)

Prof. Alberto Zambon
University of Padova (Italy)
CV residual risk: what is this? Role of lipids and inflammation and how to identify the patient

Prof. John Chapman
Pitié-Salpétrière Hospital, Paris (France)
Icosapent Ethyl MoA: what do we know?

Prof. Xavier Garcia-Moll
Hospital de la Santa Creu i Sant Pau, Barcelona (Spain)
Icosapent Ethyl: Evidence and guidelines recommendations

SEC= Sociedad Española de Cardiología, that is!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News